You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

Sigma-1 Receptor Agonist

Showing 1 - 25 of >10,000
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Incidence of Retained Gastric Food on Endoscopy

Not yet recruiting
  • Gastric Content Aspiration
  • Esophagogastroduodenoscopy
  • (no location specified)
May 16, 2023

Caveolin 1 Deficiency in Response to Glucagon-like Peptide 1

Not yet recruiting
  • Overweight and Obesity
  • 24-hour ambulatory blood pressure
  • Liberal salt diet
  • (no location specified)
Oct 4, 2023

Breast Cancer, Breast Tumor Trial in Philadelphia ([18F]ISO-1)

Active, not recruiting
  • Breast Cancer
  • Breast Neoplasm
  • Philadelphia, Pennsylvania
    University of Pennsylvania Hospital
Jan 17, 2023

Stroke, Stroke, Acute, Stroke, Ischemic Trial in Linyi, Hong Kong (Semaglutide)

Recruiting
  • Stroke
  • +3 more
  • Linyi, Shangdong, China
  • +1 more
Jun 24, 2023

Glucagon-like Peptide-1 Receptor Agonists According to Type 2

Recruiting
  • Diabetes Mellitus, Type 2
  • GLP-1 receptor agonist
  • Bari, Italy
    Azienda Ospedaliero-Universitaria Policlinico Bari
Nov 4, 2023

Glucagon-like Peptide 1 Receptor Agonists and Mental Health

Not yet recruiting
  • Diabetes Mellitus
  • +2 more
  • GLP-1 receptor agonist
  • (no location specified)
Aug 4, 2022

Wolfram Syndrome Trial (Tirzepatide)

Not yet recruiting
  • Wolfram Syndrome
  • (no location specified)
Dec 12, 2022

Imaging of in Vivo Sigma-2 Receptor Expression With 18F-ISO-1

Terminated
  • METASTATIC BREAST CANCER
  • Positron emission tomography (PET/CT) imaging
  • radiotracer [18F]ISO-1
  • Philadelphia, Pennsylvania
    Abramson Cancer Center of the University of Pennsylvania
Nov 10, 2021

Healthy Trial in Singapore (LY3537021, Liraglutide, Placebo)

Active, not recruiting
  • Healthy
  • Singapore, Singapore
    Lilly Centre for Clinical Pharmacology
Nov 22, 2022

Type 2 Diabetes Trial in Xuzhou (GLP-1 receptor agonist)

Recruiting
  • Type 2 Diabetes Mellitus
  • GLP-1 receptor agonist
  • Xuzhou, Jiangsu, China
    Department of Endocrinology
Apr 16, 2022

Asthma Trial in Nashville (Semaglutide Pen Injector 2.4mg weekly, Placebo)

Not yet recruiting
  • Asthma
  • Semaglutide Pen Injector 2.4mg weekly
  • Placebo
  • Nashville, Tennessee
    Vanderbilt University Medical Center
Jun 22, 2022

Alcohol Abuse, Alcohol Addiction, Alcohol Dependence Trial in Frederiksberg (Semaglutide Injectable Product, Placebo)

Recruiting
  • Alcohol Abuse
  • +3 more
  • Semaglutide Injectable Product
  • Placebo
  • Frederiksberg, Denmark
    Psychiatric Center Copenhagen, Frederiksberg Hospital
Jun 13, 2023

Ischemic Stroke Trial in Herlev (Byetta, Normosaline)

Recruiting
  • Ischemic Stroke
  • Herlev, Denmark
    Department of Neurology, Herlev-Gentofte Hospital
Nov 13, 2021

Osteoporosis, Postmenopausal, Diabetes, Type 2 Trial in Jackson (GLP-1 receptor agonist)

Recruiting
  • Osteoporosis, Postmenopausal
  • Diabetes Mellitus, Type 2
  • GLP-1 receptor agonist
  • Jackson, Mississippi
    University of Mississippi Medical Center
Aug 5, 2022

Kidney Transplant Recipients Trial in Toronto (Dapagliflozin 10 MG, Semaglutide, 1.0 mg/mL)

Not yet recruiting
  • Kidney Transplant Recipients
  • Dapagliflozin 10 MG
  • Semaglutide, 1.0 mg/mL
  • Toronto, Ontario, Canada
    Toronto General Hospital
Jul 6, 2023

Obesity Trial in Mansourah, Mansoura (Liraglutide)

Recruiting
  • Obesity
  • Mansourah, Dakhlia, Egypt
  • +1 more
Feb 24, 2022

Neat OGTT, OGTT With Added Sucralose, OGTT With Added Lactisole Trial in New Brunswick (TAS1R2/3 agonist or antagoinst admixture

Completed
  • Neat OGTT
  • +2 more
  • TAS1R2/3 agonist or antagoinst admixture to oral glucose tolerance test
  • New Brunswick, New Jersey
    Rutgers, Department of Nutritional Sciences
Jun 2, 2023

Estrogen Receptor-Positive, HER2-Negative Advanced Breast Cancer Trial (Giredestrant, Fulvestrant, Abemaciclib)

Not yet recruiting
  • Estrogen Receptor-Positive, HER2-Negative Advanced Breast Cancer
  • (no location specified)
Sep 26, 2023

Health Volunteers, Huntington Disease Trial in Leipzig (pridopidine (90 mg))

Completed
Has Results
  • Health Volunteers, Huntington Disease
  • pridopidine (90 mg)
  • Leipzig, Germany
    Teva Investigational Site 32648
Nov 18, 2021

Spinal Cord Injuries Trial in Toledo (Rimonabant)

Not yet recruiting
  • Spinal Cord Injuries
  • Toledo, Spain
    Hospital Nacional de Paraplejicos
Nov 14, 2022

Morbid Obesity, Metabolic Syndrome, Diabetes Trial in Columbia (GLP-1 receptor agonist)

Not yet recruiting
  • Morbid Obesity
  • +4 more
  • GLP-1 receptor agonist
  • Columbia, Missouri
    University of Missouri Hospital
Nov 20, 2023

Type 2 Diabetes, Obesity Trial in Sherbrooke (drug, other, diagnostic test, procedure)

Recruiting
  • Type 2 Diabetes
  • Obesity
  • Formoterol Fumarate 12 micrograms Inhalation Powder
  • +8 more
  • Sherbrooke, Quebec, Canada
    Centre de recherche du CHUS
Sep 22, 2022

Breast Cancer Trial in Worldwide (GDC-9545, Palbociclib, LHRH Agonist)

Active, not recruiting
  • Breast Cancer
  • Aurora, Colorado
  • +23 more
Jan 30, 2023

Healthy Controls Trial in Stanford ([18F]-FTC-146)

Active, not recruiting
  • Healthy Controls
  • Stanford, California
    Department of Psychiatry and Behavioral Sciences
Jun 15, 2022

Diabetes, Diabetic Kidney Disease Trial in Sha Tin (Dulaglutide, Insulin Degludec, Continuous glucose monitor)

Recruiting
  • Diabetes Mellitus
  • Diabetic Kidney Disease
  • Sha Tin, Hong Kong
    Prince of Wales Hospital
Nov 8, 2022